Chromomycin A3
Names | |
---|---|
IUPAC name
(1S)-1-C-((2S,3S)-7-{[4-O-acetyl-2,6-dideoxy-3-O-(2,6-dideoxy-4-O-methyl-α-D-lyxo-hexopyranosyl)-β-D-lyxo-hexopyranosyl]oxy}-3-{[4-O-acetyl-2,6-dideoxy-3-C-methyl-α-L-arabino-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-arabino-hexopyranosyl-(1→3)-2,6-dideoxy-β-D-arabino-hexopyranosyl]oxy}-5,10-dihydroxy-6-methyl-4-oxo-1,2,3,4-tetrahydroanthracen-2-yl)-5-deoxy-1-O-methyl-D-xylulose | |
Other names
Toyomycin | |
Identifiers | |
7059-24-7 | |
ChEMBL | ChEMBL216639 |
ChemSpider | 16735739 |
PubChem | 656673 |
| |
Properties | |
C57H82O26 | |
Molar mass | 1,183.26 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Chromomycin A3 or Toyomycin is an anthraquinone antibiotic glycoside produced by the fermentation of an certain strain of Streptomyces griseus.
Uses
- in-vitro membrane-impermeant G/C-specific fluorescent DNA-binding dye
- in-vitro antibiotic
- in-vitro anticancer drug that inhibits RNA synthesis
|
This article is issued from Wikipedia - version of the Monday, November 30, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.